CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue rose 7.3% year-over-year to $106.1 billion, above analyst estimates of $100.11 billion.
Medical benefit costs came in below forecasts.
CVS Health Wednesday reported second quarter net income nearly tripled to $2.9 billion compared to the year-ago quarter as the company gets a better handle on rising costs in its Aetna health plans.
CVS Health said it will revamp its weight management program through a partnership with Eli Lilly as the company lifted its full-year outlook and reported a nearly threefold increase in its second-quarter profit.
CVS Health on Wednesday raised its annual profit forecast to reflect a better-than-expected second quarter marked by a more profitable mix of drugs in its pharmacy business and bonus payments for its highly rated government health plans.
CVS Health blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit Aetna shows signs of recovery. All three of the healthcare giant's business segments – insurance, pharmacy and health services —surpassed Wall Street's revenue expectations.
CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE
Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58 Generated year-to-date cash flow from operations of $10.6 billion Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.84 to $7.04 from $6.24 to $6.44 Adjusted EPS guidance range to $7.90 to $8.10 from $7.30 to $7.50 Cash flow fro...